News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
390,100 Results
Type
Article (27042)
Company Profile (62)
Press Release (362996)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (106173)
Career Advice (452)
Deals (17110)
Drug Delivery (52)
Drug Development (49151)
Employer Resources (50)
FDA (12383)
Job Trends (8637)
News (189388)
Policy (19888)
Tag
Academia (1826)
Accelerated approval (3)
Adcomms (8)
Allergies (75)
Alliances (27356)
ALS (57)
Alzheimer's disease (842)
Antibody-drug conjugate (ADC) (56)
Approvals (12447)
Artificial intelligence (179)
Autoimmune disease (11)
Automation (4)
Bankruptcy (142)
Best Places to Work (7089)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (41)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (203)
Cancer (1486)
Cardiovascular disease (125)
Career advice (410)
Career pathing (13)
CAR-T (73)
Cell therapy (211)
Cervical cancer (14)
Clinical research (41304)
Collaboration (464)
Compensation (134)
Complete response letters (9)
COVID-19 (2018)
CRISPR (17)
C-suite (147)
Cystic fibrosis (47)
Data (1624)
Decentralized trials (2)
Denatured (18)
Depression (31)
Diabetes (181)
Diagnostics (3768)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (56)
Drug pricing (55)
Drug shortages (21)
Duchenne muscular dystrophy (57)
Earnings (38141)
Editorial (22)
Employer branding (7)
Employer resources (46)
Events (52859)
Executive appointments (459)
FDA (13442)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (426)
Gene editing (43)
Generative AI (10)
Gene therapy (145)
GLP-1 (419)
Government (3229)
Grass and pollen (4)
Guidances (94)
Healthcare (12513)
Huntington's disease (11)
IgA nephropathy (17)
Immunology and inflammation (42)
Indications (19)
Infectious disease (2100)
Inflammatory bowel disease (83)
Inflation Reduction Act (4)
Influenza (35)
Intellectual property (54)
Interviews (41)
IPO (7186)
IRA (19)
Job creations (1853)
Job search strategy (380)
Kidney cancer (7)
Labor market (13)
Layoffs (175)
Leadership (4)
Legal (3648)
Liver cancer (57)
Lung cancer (235)
Lymphoma (101)
Machine learning (5)
Management (17)
Manufacturing (114)
MASH (53)
Medical device (12945)
Medtech (12948)
Mergers & acquisitions (10232)
Metabolic disorders (451)
Multiple sclerosis (55)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (10)
Neuroscience (1184)
NextGen: Class of 2025 (3976)
Non-profit (2856)
Now hiring (17)
Obesity (224)
Opinion (73)
Ovarian cancer (56)
Pain (66)
Pancreatic cancer (59)
Parkinson's disease (91)
Partnered (11)
Patents (124)
Patient recruitment (85)
Peanut (37)
People (34975)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11958)
Phase II (17897)
Phase III (14675)
Pipeline (790)
Policy (63)
Postmarket research (1677)
Preclinical (3883)
Press Release (23)
Prostate cancer (79)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (195)
Real estate (2866)
Recruiting (18)
Regulatory (14514)
Reports (17)
Research institute (1706)
Resumes & cover letters (49)
Rett syndrome (3)
RNA editing (3)
RSV (20)
Schizophrenia (53)
Series A (69)
Series B (53)
Service/supplier (3)
Sickle cell disease (22)
Special edition (5)
Spinal muscular atrophy (102)
Sponsored (14)
Startups (2152)
Stomach cancer (8)
Supply chain (39)
Tariffs (14)
The Weekly (8)
Vaccines (495)
Venture capitalists (13)
Weight loss (142)
Women's health (18)
Worklife (4)
Date
Today (62)
Last 7 days (486)
Last 30 days (1637)
Last 365 days (18714)
2025 (6518)
2024 (20352)
2023 (23434)
2022 (32085)
2021 (34622)
2020 (32720)
2019 (28748)
2018 (22048)
2017 (19205)
2016 (18377)
2015 (21464)
2014 (16199)
2013 (13389)
2012 (14507)
2011 (14774)
2010 (13352)
Location
Africa (366)
Alabama (17)
Alaska (2)
Arizona (122)
Arkansas (10)
Asia (24889)
Australia (3939)
California (3261)
Canada (1261)
China (379)
Colorado (169)
Connecticut (187)
Delaware (122)
Europe (49326)
Florida (565)
Georgia (134)
Idaho (33)
Illinois (367)
India (16)
Indiana (233)
Iowa (5)
Japan (128)
Kansas (74)
Kentucky (12)
Louisiana (8)
Maine (27)
Maryland (658)
Massachusetts (2233)
Michigan (109)
Minnesota (281)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (35)
New Hampshire (60)
New Jersey (1170)
New Mexico (9)
New York (996)
North Carolina (578)
North Dakota (4)
Northern California (1443)
Ohio (134)
Oklahoma (3)
Oregon (25)
Pennsylvania (881)
Puerto Rico (7)
Rhode Island (26)
South America (526)
South Carolina (23)
Southern California (1242)
Tennessee (79)
Texas (577)
United States (13441)
Utah (117)
Virginia (83)
Washington D.C. (42)
Washington State (252)
West Virginia (3)
Wisconsin (43)
390,100 Results for "varian medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Agreement Between Varian and Embolx Paves the Way for Advanced Image-Guided Therapies for Cancer
March 31, 2025
·
3 min read
RayCare 2024A interoperable with Varian TrueBeam
RaySearch Laboratories AB is proud to announce that the oncology information system RayCare®* 2024A has been certified to be interoperable with Varian TrueBeam® linear accelerators, version 3.0.
May 16, 2024
·
2 min read
Biotech Bay
Varian Receives FDA 510(k) Clearance for TrueBeam and Edge Radiotherapy Systems Featuring HyperSight Imaging Solution
Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for TrueBeam and Edge radiotherapy systems featuring HyperSight imaging solution.
February 29, 2024
·
4 min read
Deals
Varian Acquires Aspekt Solutions, Strengthening Advanced Oncology Solutions Offering
Varian, a Siemens Healthineers company, announced today that it has acquired Aspekt Solutions, a leading provider of medical physics, dosimetry, and strategy consultation services.
September 26, 2023
·
3 min read
Press Releases
Varian Launches HyperSight™ for TrueBeam in Asia Pacific: Boosting Accuracy and Efficiency in Radiotherapy Treatment
August 26, 2024
·
3 min read
News
Varian Announces 10-year Transformational Oncology Collaboration with Ballad Health to Bring Advanced Treatment Solutions to Rural Communities
September 24, 2024
·
4 min read
FDA
Varian Announces Future-Focused, Integrated Microwave Ablation Ecosystem with IntelliBlate
July 29, 2024
·
4 min read
Varian and Nova Scotia Health Form First Multi-Disciplinary Oncology Partnership to Catalyze Advancements in Cancer Care
Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship.
January 4, 2024
·
5 min read
RayCare is interoperable with Varian TrueBeam
RaySearch Laboratories AB is proud to announce that the oncology information system RayCare®* can connect to Varian TrueBeam® linear accelerators.
May 24, 2023
·
2 min read
Press Releases
Varian Announces Powerful Functionality, Expanding Versatility and Connectivity for its Ethos Adaptive Radiotherapy System
July 22, 2024
·
3 min read
1 of 39,010
Next
